Valuation: BlinkLab Limited

Market Cap 9.96Cr 6.97Cr 6.1Cr 5.62Cr 5.17Cr 9.79Cr 670.87Cr 67Cr 26Cr 327.9Cr 26Cr 26Cr 1.13TCr P/E 2026 *
-6.5x
P/E 2027 * -6.5x
Enterprise Value 9.56Cr 6.69Cr 5.85Cr 5.4Cr 4.96Cr 9.4Cr 643.93Cr 64Cr 25Cr 314.74Cr 25Cr 25Cr 1.08TCr EV / Sales 2026 *
294x
EV / Sales 2027 * 646x
Free-Float
80.71%
Yield 2026 *
-
Yield 2027 * -
1 day-4.62%
1 week-3.88%
1 month-1.59%
3 months-14.48%
6 months-35.42%
Current year-23.46%
1 week 0.6
Extreme 0.605
0.68
1 month 0.58
Extreme 0.575
0.72
Current year 0.57
Extreme 0.57
1.07
1 year 0.4
Extreme 0.405
1.1
3 years 0.2
Extreme 0.205
1.1
5 years 0.2
Extreme 0.205
1.1
10 years 0.2
Extreme 0.205
1.1
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 17/08/2021
Chief Tech/Sci/R&D Officer - 17/08/2021
Corporate Officer/Principal - 17/08/2021
Director TitleAgeSince
Director/Board Member - 18/12/2025
Director/Board Member - 17/08/2021
Chairman - 15/12/2023
Change 5-day change 1-year change 3-year change Capi.($)
-4.62%-3.88%+29.17% - 6.97Cr
+2.78%+3.21%-21.78%+14.60% 2,93900Cr
+0.03%+1.16%-9.97%+715.61% 32TCr
-4.50%-4.68%+262.99%+874.57% 13TCr
-1.41%-0.68%+16.81%+54.32% 10TCr
-2.32%+1.29%+88.15%+143.67% 9.41TCr
-0.15%-2.12%-25.27%-6.35% 8.14TCr
+1.89%+5.74%-29.63%+78.18% 6.82TCr
+2.85%-3.02%+2.57%+62.53% 4.53TCr
+4.77%+3.54%-49.26%+32.72% 4.09TCr
Average -0.27%-1.75%+26.38%+218.87% 38.17TCr
Weighted average by Cap. +0.24%-1.07%-7.94%+107.36%

Financials

2026 *2027 *
Net sales 3L 2L 2L 2L 2L 3L 2.19Cr 21.9L 9L 1.07Cr 9L 8L 3.69Cr 1L 1L 88.73T 81.85T 75.24T 1L 97.65L 10L 4L 47.73L 4L 4L 1.65Cr
Net income -60.5L -42.34L -37.02L -34.15L -31.39L -59.48L -41Cr -4.08Cr -1.6Cr -20Cr -1.59Cr -1.56Cr -69Cr -74L -51.79L -45.28L -41.77L -38.4L -72.76L -50Cr -4.99Cr -1.96Cr -24Cr -1.94Cr -1.9Cr -84Cr
Net Debt -40L -28L -24.48L -22.58L -20.76L -39.33L -27Cr -2.7Cr -1.06Cr -13Cr -1.05Cr -1.03Cr -45Cr -60L -41.99L -36.71L -33.87L -31.13L -58.99L -40Cr -4.04Cr -1.59Cr -20Cr -1.58Cr -1.54Cr -68Cr
Logo BlinkLab Limited
BlinkLab Limited is an Australia-based digital healthcare company focused on Artificial intelligence (AI) powered diagnostics. The Company has fully developed a smartphone based diagnostic platform for autism, Attention-Deficit/Hyperactivity Disorder (ADHD), schizophrenia, and other neurodevelopmental conditions. Its product is an autism diagnostic test that leverages the power of smartphones, AI and machine learning to deliver screening tests specifically designed for children as young as over 18 months old. Its pipeline includes BlinkLab Dx 1 and BlinkLab Dx N. Its BlinkLab Dx 1 is an autism diagnostic adjunct. Its BlinkLab Dx N is an ADHD diagnostic adjunct.
Employees
-
Date Price Change Volume
16/26/16 A$0.6200 -4.62% 1,81,543
15/26/15 A$0.6500 +4.84% 2,23,532
14/26/14 A$0.6200 -2.36% 1,31,437
13/26/13 A$0.6350 0.00% 1,25,598
10/26/10 A$0.6350 -1.55% 44,313
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.6500AUD
Average target price
1.830AUD
Spread / Average Target
+181.54%

Annual profits - Rate of surprise